Editorial

The threat of colistin resistance among carbapenem-resistant Klebsiella pneumoniae isolates in Iran

Abstract

No Abstract

Nation RL, Velkov T, Li J. Colistin and polymyxin B: peas in a pod, or chalk and cheese? Clin Infect Dis 2014;59:88-94.

Cheah S-E, Li J, Tsuji BT, Forrest A, Bulitta JB, Nation RL. Colistin and polymyxin B dosage regimens against Acinetobacter baumannii: differences in activity and the emergence of resistance. Antimicrob Agents Chemother 2016;60:3921-3933.

Tran TB, Velkov T, Nation RL, Forrest A, Tsuji BT, Bergen PJ, et al. Pharmacokinetics/pharmacodynamics of colistin and polymyxin B: are we there yet? Int J Antimicrob Agents 2016;48:592-597.

Haeili M, Javani A, Moradi J, Jafari Z, Feizabadi MM, Babaei E. MgrB alterations mediate colistin resistance in Klebsiella pneumoniae isolates from Iran. Front Microbiol 2017;8:2470.

Haeili M, Kafshdouz M, Feizabadi MM. Molecular mechanisms of colistin resistance among pandrug-resistant isolates of Acinetobacter baumannii with high case-fatality rate in intensive care unit patients. Microb Drug Resist 2018; doi: 10.1089/mdr.2017.0397. [Epub ahead of print].

Ah Y-M, Kim A-J, Lee J-Y. Colistin resistance in Klebsiella pneumoniae. Int J Antimicrobial Agents 2014;44:8-15.

Files
IssueVol 10 No 2 (2018) QRcode
SectionEditorial
Keywords
No keywords###
Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
How to Cite
1.
Haeili M, Feizabadi MM. The threat of colistin resistance among carbapenem-resistant Klebsiella pneumoniae isolates in Iran. Iran J Microbiol. 2018;10(2):72-73.